Rulid Tab.

Ingredient

Roxithromycin

Content

150mg

Indication

Effective Species: Streptococcus, Streptococcus pneumonia, Neisseria meningitidis, Neisseria gonorrhoeae, Bordetella pertussis, bacteria cocci associated with catarrh, Corynebacterium diphtheria, Clostridium perfringens, Mycoplasma pneumonia, Chlamydia trachomatis, Ureaplasma urealyticum, Legionella pneumophila, Campylobacter pylori, Campylobacter jejuni, Gardnerella vaginalis, Haemophilus influenza, Staphylococcus aureus, Vibrio cholera, and Chlamydia psittaci
Indications:
– respiratory infectious disease: pharyngolaryngitis, acute bronchitis, tonsillitis, bacterial pneumonia, mycoplasma pneumonia, etc.
– genital infections and sexually transmitted diseases, excluding infection by Neisseria gonorrhoeae
– otitis media and sinusitis
– folliculitis, furuncle, furunculosis, carbuncle, erysipelas, cellulitis, lymphangitis(lymphadenitis), whitlow, purulent paronychia, subcutaneous abscess, hidradenitis, acne conglobate, and infectious atheroma
– prophylaxis of infection in case of contact with meningococcal meningitis patients
– pericoronitis and periodontitis

Selectol Tab.

Ingredient

Celiprolol Hydrocholoride

Content

200mg

Indication

1) Treatment of hypertension
2) Management of angina pectoris.

Sentil Tab. 5mg

Ingredient

Clobazam

Content

5mg

Indication

1) Treatment of anxiety, tension
2) Treatment of anxiety, tension in mental retardation, autonomic dysfunction, sleep disorder, organic mental disorder
3) Adjunctive treatment of seizures when antiepileptic drug monotherapy is ineffective at controlling seizures

Solian Tab. 100mg

Ingredient

Amisulpride

Content

100mg

Indication

Treatment of schizophrenia

Solian Tab. 200mg

Ingredient

Amisulpride

Content

200mg

Indication

Treatment of schizophrenia

Solian Tab. 400mg

Ingredient

Amisulpride

Content

400mg

Indication

Treatment of schizophrenia

Soliris Inj.

Ingredient

Eculizumab

Content

300mg/30ml

Indication

1) Treatment of paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. Evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history
2) Treatment of atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy
Limitation of use: Eculizumab is not indicated for the treatment of patients with Shiga toxin-producing Escherichia coli-related hemolytic uremic syndrome.
3) Treatment of refractory generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive

Stilnox CR Tab. 12.5mg

Ingredient

Zolpidem Tartrate

Content

12.5mg

Indication

Short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Stilnox CR Tab. 6.25mg

Ingredient

Zolpidem Tartrate

Content

6.25mg

Indication

Short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Stilnox Tab. 10mg

Ingredient

Zolpidem Tartrate

Content

10mg

Indication

Short-term treatment of insomnia in adults